News for Alpha Cognition Inc. (ACOG.V)

Alpha Cognition Inc. (ACOG) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Here is how Alpha Cognition Inc. (ACOG) and Astellas Pharma Inc. (ALPMY) have performed compared to their sector so far this year.

Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?

We came across a bullish thesis on Alpha Cognition Inc. Common Stock (ACOG) by anygal on r/investing on Reddit. In this article, we will summarize the bulls’ thesis on ACOG. Alpha Cognition Inc.

Alpha Cognition Inc. (ACOG) successfully launched ZUNVEYL in the U.S. long-term care market on March 17, 2025. ZUNVEYL generated net product revenues of

Alpha Cognition Inc. (ACOG) delivered earnings and revenue surprises of 65.52% and 26.78%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Alpha Cognition Inc. (Nasdaq: ACOG) (”œAlpha Cognition”, or the ”œCompany”) today announced its financial results for the first quarter ended March 31, 2

Alpha Cognition Inc. launches ZUNVEYL in the U.S. market, targeting long-term care facilities. First quarter 2025 revenues include $347,000 from ZUNVEYL

Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today will announce financia

Alpha Cognition Inc. (ACOG) will report first quarter 2025 financial results on May 15, 2025. The company is focused on developing treatments for neurod

California-based Regulus Therapeutics Inc. (RGLS), a clinical-stage biopharmaceutical company is up over 132 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Alpha Cognition (ACOG) is set to participate in the D. Boral Capital Inaugural Global Conference on May 14, 2025. CEO Michael McFadden will host one-on-

Alpha Cognition Inc. (NASDAQ: ACOG) (the ”œCompany” or ”œAlpha Cognition”) today announced three upcoming presentations at the 2025 Alzheimer's Associati

Alpha Cognition Inc. (ACOG) to present clinical data on ZUNVEYL at the 2025 AAIC. ZUNVEYL is commercially launched and approved by the FDA in 2024. T

Shares of ServiceNow, Inc. NOW rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results. Serv...

California-based Ensysce Biosciences, Inc. (ENSC) is up over 133 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

California-based Ensysce Biosciences, Inc. (ENSC) is up over 133 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Ireland-based SMX (Security Matters) Public Limited Co (SMX) is up over 50 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Ireland-based SMX (Security Matters) Public Limited Co (SMX) is up over 50 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.